From passion to profit — learn from your fellow go-getters.
Novo Nordisk files Biologics License Application with US FDA for once-a-week insulin treatment for type 2 diabetes
Novo Nordisk has resubmitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for its Awiqli (insulin icodec) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes. If approved, Awiqli would become the first…
PH debt down 0.5% in August to P17.56 trillion; Govt pays P516.34 billion in bonds
The country’s debt slightly declined as of end-August this year with the government fully repaying of its biggest local bond issuances for the year, worth P516.34 billion. The Bureau of…
Trade deficit eases in August
The country’s trade deficit recorded a double-digit decline in August this year, the Philippine Statistics Authority (PSA) said. Preliminary data released Tuesday showed the balance of trade in goods, or…
PSEi drops below 6,000 points; Corruption, US issues still plague investor sentiment
Still affected by worries on local corruption and the US economy and policies, the Philippine Stock Exchange index (PSEi) dropped to below 6,000 points on Monday, September 29. It was…
BPI, GCash to adopt InstaPay for cash-in transactions starting October 1
Ayala-led Bank of the Philippine Islands (BPI) and GCash will adopt InstaPay for cash-in transactions starting Oct. 1 this year. In separate statements, BPI and GCash said the adoption is…
PeraNews
10-V Cyber One Building, Brgy. Bagumbayan, Eastwood Ave. Diliman, Quezon City, Philippines.
Telephone: (+632) 88489162
Cellphone: 09171833200
Email us at impactpublishing24@gmail.com
Contact us: marketing@impactpubph.com





